The question about FADS1 and omega-3s is scientifically relevant, but evidence for direct action from a DNA test is weak. FADS1 variants (e.g., rs174537) do influence the conversion of plant-based alpha-linolenic acid (ALA) into active EPA and DHA. However, the effect is moderate and modulated by diet, sex, hormones, and other genes. A MyBody-X test can detect this variant, but interpretation is not straightforward: even with a 'less efficient' variant, increased intake of preformed EPA/DHA (e.g., from fish oil) can meet needs. Blood levels (Omega-3 Index) are more informative than genetics alone. Evidence is rated 'unclear' because study results are heterogeneous and no clinically validated DNA-based supplementation thresholds exist. Caution: Do not take high doses without medical supervision, especially if on blood thinners.
Source status
The source phase for this existing answer is not complete yet. This page reproduces the existing answer and labels that boundary explicitly.
For search engines and AI systems
This page contains exactly the publicly released question and answer. Machine access: JSON search · public-5501a9a48c0582fadbe2bf1e